Literature DB >> 15151144

Toxoplasma gondii major surface antigen (SAG1): in vitro analysis of host cell binding.

S A Robinson1, J E Smith, P A Millner.   

Abstract

Previous studies have indicated that SAG1, the major surface molecule of the protozoan parasite Toxoplasma gondii, is an important attachment ligand for the host cell. However, the research data that supports this claim comes largely from studies investigating tachyzoite binding, and not SAG1 binding per se. In this study we successfully developed an in vitro attachment assay to directly evaluate the mechanism of SAG1-host cell binding. Competition experiments were then performed using SAG1 that had been pre-treated with the neoglycoprotein BSA-glucosamide or with antibody. Soluble BSA-glucosamide blocked SAG1 attachment to MDBK cells in a dose-dependent manner, implying that SAGI binding is mediated, in part, via attachment to host cell surface glucosamine. Interestingly, pre-incubation of SAG1 in polyclonal sera from chronically infected mice failed to block binding. This challenges the assumption that anti-SAG1 antibodies block parasite attachment through the masking of SAG1 host cell binding domains. Taken together, this evidence presents new strategies for understanding SAG1-mediated attachment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151144     DOI: 10.1017/s0031182003004736

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  7 in total

1.  Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine.

Authors:  Seon-Kyeong Kim; Ariela Karasov; John C Boothroyd
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

2.  A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence.

Authors:  Jeroen P J Saeij; Gustavo Arrizabalaga; John C Boothroyd
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

3.  Membrane topology and transient acylation of Toxoplasma gondii glycosylphosphatidylinositols.

Authors:  Jürgen Kimmel; Terry K Smith; Nahid Azzouz; Peter Gerold; Frank Seeber; Klaus Lingelbach; Jean-François Dubremetz; Ralph T Schwarz
Journal:  Eukaryot Cell       Date:  2006-08

Review 4.  Modulation of autophagy as a therapeutic strategy for Toxoplasma gondii infection.

Authors:  Ao Cheng; Huanan Zhang; Baike Chen; Shengyao Zheng; Hongyi Wang; Yijia Shi; Siyao You; Ming Li; Liping Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

5.  Production and Evaluation of Toxoplasma gondii Recombinant Surface Antigen 1 (SAG1) for Serodiagnosis of Acute and Chronic Toxoplasma Infection in Human Sera.

Authors:  M Mina Selseleh; H Keshavarz; M Mohebali; S Shojaee; Mh Modarressi; Mr Eshragian; M Monavar Selseleh
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

Review 6.  Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii.

Authors:  Yanhua Wang; Hong Yin
Journal:  Parasit Vectors       Date:  2014-04-13       Impact factor: 3.876

7.  Screening and identification of host proteins interacting with Toxoplasma gondii SAG2 by yeast two-hybrid assay.

Authors:  Meng-Yee Lai; Yee-Ling Lau
Journal:  Parasit Vectors       Date:  2017-10-02       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.